Management of Systemic Sclerosis Patients in the COVID-19 Era: The Experience of an Expert Specialist Reference Center
Objective: COVID-19 pandemic represents a serious health emergency that severely compromised our Public Health system, resulting in a rapid and forced reorganization and involved the management of chronic diseases too. The Scleroderma Unit of Modena and Reggio Emilia follows more than 600 patients s...
Main Authors: | Amelia Spinella, Luca Magnani, Marco De Pinto, Chiara Marvisi, Luca Parenti, Gianluigi Bajocchi, Carlo Salvarani, Maria Teresa Mascia, Dilia Giuggioli |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-03-01
|
Series: | Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine |
Online Access: | https://doi.org/10.1177/11795484211001349 |
Similar Items
-
One‐year clinical experience on the use of Nintedanib in systemic sclerosis
by: Luca Magnani, et al.
Published: (2023-06-01) -
Infections of scleroderma digital ulcers: a single center cohort retrospective study
by: Dilia Giuggioli, et al.
Published: (2021-10-01) -
Use of Neem oil and for treatment of calcinosis-related skin ulcers in systemic sclerosis
by: Dilia Giuggioli, et al.
Published: (2020-10-01) -
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study
by: Angela Toss, et al.
Published: (2021-06-01) -
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast Study
by: Chrystel Isca, et al.
Published: (2022-12-01)